Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / replimune continuing to justify the bear thesis for

REPL - Replimune: Continuing To Justify The Bear Thesis (For Now)

Replimune Group Inc.

2024-05-22 09:47:37 ET

Summary

  • Replimune Group, Inc.'s stock has fallen 35% in 2024, and an inflection point is not expected yet.
  • The company is working on RP1, an oncolytic virus therapy, and has shared positive results from their ARTACUS trial.
  • Replimune plans to submit a BLA for RP1 approval in melanoma, but this is far from guaranteed, especially in 2024.

...

For further details see:

Replimune: Continuing To Justify The Bear Thesis (For Now)
Stock Information
Company Name: Replimune Group Inc.
Stock Symbol: REPL
Market: NASDAQ
Website: replimune.com
Menu
REPL REPL Quote REPL Short REPL News REPL Articles REPL Message Board
Get REPL Alerts

News, Short Squeeze, Breakout and More Instantly...